Thursday Jul 03, 2025

On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse

In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision.

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of โ€“ and a chapter contributor to โ€“ the first edition of "๐˜๐˜ข๐˜ฏ๐˜ฅ๐˜ฃ๐˜ฐ๐˜ฐ๐˜ฌ ๐˜ฐ๐˜ง ๐˜Ž๐˜ฆ๐˜ฏ๐˜ฆ๐˜ณ๐˜ข๐˜ญ๐˜ช๐˜ป๐˜ฆ๐˜ฅ ๐˜—๐˜ข๐˜ช๐˜ณ๐˜ธ๐˜ช๐˜ด๐˜ฆ ๐˜Š๐˜ฐ๐˜ฎ๐˜ฑ๐˜ข๐˜ณ๐˜ช๐˜ด๐˜ฐ๐˜ฏ๐˜ด: ๐˜”๐˜ฆ๐˜ต๐˜ฉ๐˜ฐ๐˜ฅ๐˜ด ๐˜ง๐˜ฐ๐˜ณ ๐˜—๐˜ข๐˜ต๐˜ช๐˜ฆ๐˜ฏ๐˜ต-๐˜Š๐˜ฆ๐˜ฏ๐˜ต๐˜ณ๐˜ช๐˜ค ๐˜ˆ๐˜ฏ๐˜ข๐˜ญ๐˜บ๐˜ด๐˜ช๐˜ด", recently published by the Routledge Taylor & Francis Group.

The conversation explores generalised pairwise comparisons (or GPCs), applications in various disease areas, implications for regulatory approvals and benefit-risk analyses, and considerations for patient-centricity in clinical research and treatment decisions.

You can also listen to episode 189a of theโ€ฏpharmaphorum podcastโ€ฏin the player below, download the episode to your computer, or find it - and subscribe to the rest of the series โ€“ onย Apple Podcasts,ย Spotify, Overcast, Pocket Casts,ย Podbean, and pretty much wherever else you download your other podcasts from.

Comment (0)

No comments yet. Be the first to say something!

ยฉ 2022 Pharmaphorum

Podcast Powered By Podbean

Version: 20241125